Location History:
- Macclesfield, EN (1977 - 1978)
- Broken Cross, GB (1993)
- Macclesfield, GB (1978 - 1997)
Company Filing History:
Years Active: 1977-1997
Title: Innovations of Bernard J McLoughlin in Pharmaceutical Chemistry
Introduction
Bernard J McLoughlin is a prominent inventor based in Macclesfield, Great Britain. He has made significant contributions to the field of pharmaceutical chemistry, particularly with innovations pertaining to cardiovascular agents. With a total of 19 patents to his name, McLoughlin’s work has advanced the development of novel compounds that show promise in medical applications.
Latest Patents
Among his latest inventions, McLoughlin has developed aminopyridinium compounds that exhibit interesting properties due to the various functional groups involved. These compounds are potentially beneficial in multiple pharmaceutical applications, especially in regulating the cardiovascular system. Another notable patent involves amino 1,3,5-triazine derivatives, designed as agents to positively influence the cardiovascular system. The innovative compounds from this patent also include formulations that may enhance physiological function by operating through mechanisms associated with the sino-atrial node.
Career Highlights
McLoughlin has collaborated closely with well-known institutions and has been associated with Imperial Chemical Industries Limited, a company recognized for its contributions to research and development in the chemical sector. His expertise in the creation of novel chemical entities has allowed him to file a number of essential patents that illustrate his commitment to advancing the capabilities of pharmaceutical chemistry.
Collaborations
Throughout his career, Bernard has worked alongside esteemed colleagues such as Rodney B Hargreaves and Stuart D Mills. These collaborations have strengthened the innovative outcomes of their joint research efforts, leading to advancements in pharmaceutical formulations and production methods.
Conclusion
Bernard J McLoughlin’s contributions to the field of pharmaceutical chemistry are evident through his numerous patents and collaborative efforts with industry leaders. His groundbreaking work continues to pave the way for new developments that promise significant benefits to cardiovascular health, showcasing the impact of innovation in the field of medicine.